Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome

Journal of the Formosan Medical Association

Volumn 104, Issue 10, 2005, Pages 715-723

  Sheng, Wang Huei ^a   Chiang, Bor Luen ^a   Chang, Shan Chwen ^a   Ho, Hung Nern ^a   Wang, Jann Tay ^a   Chen, Yee Chun ^a   Hsiao, Cheng Hsiang ^a   Hseuh, Po Ren ^a   Chie, Wei Chu ^b   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hydroxycorticosteroids; Inflammatory cytokines; Respiratory distress syndrome, adult; Severe acute respiratory syndrome

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID DERIVATIVE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD STORAGE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPOXIA; INFLAMMATION; LABORATORY TEST; LYMPHOCYTOPENIA; MALE; PNEUMONIA; RETROSPECTIVE STUDY; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; VIRUS INFECTION; BLOOD; IMMUNOLOGY; MIDDLE AGED; SARS CORONAVIRUS; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TAIWAN;

EID: 33644875732     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. WHO: SARS epidemiology to date. Available at: URL: http://www. who.int/csr/don/archive/disease/severe_acute_respiratory_ syndrome/en/index.html
2. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome (SARS) Diagnosis: A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
3. WHO: Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). Available at: URL: http:// www.who.int/csr/sars/ country/en
4. Lee ML, Chen CJ, Su IJ, et al: Severe acute respiratory syndrome - Taiwan, 2003. MMWR 2003;52:461-4.
5. Lee N, Hui D, Wu A, et al: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348: 1986-94.
6. Peiris JS, Chu CM, Cheng VC, et al: Clinical progression and viral load in a community-outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361: 1767-72.
7. Ksiazek TG, Erdman D, Goldsmith CS, et al: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
8. Goodman RB, Strieter RM, Martin DP: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-11.
9. Schuttte H, Lohmeyer J, Rosseau S, et al: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary edema. Eur Respir J 1996;9:1858-67.
10. Bauer TT, Monton C, Torres A, et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000;55: 46-52.
11. Freeman B, Rathore MH, Salman E, et al: Intravenously administrated immune globulin for the treatment of infection-associated hemophagocytotic syndrome. J Pediatr 1993;123: 479-81.
12. Meduri GU: The role of host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 1993;9: 2650-70.
13. So LK, Lau AC, Yan LY, et al: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
14. WHO: Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/ 2003_04_19/en/
15. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
16. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111:1306-21.
17. Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18: 428-32.
18. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/ interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32.
19. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient group. Lancet 1993;341:643-7.
20. Tsang KW, Ho PL, Ooi GC, et al: A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
21. Poutanen SM, Low DE, Henry B, et al: Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348: 1995-2005.
22. Imashuku S: Differential diagnosis of hemophagocytotic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135-51.
23. Chen RL, Lin KG, Lin DT, et al: Immunomodulation treatment for childhood virus-associated hemophagocytic lymphohistocytosis. Br J Haematol 1995;89:282-90.
24. Briegel J, Kellermann W, Forst H, et al: Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clin Invest 1994;72:782-7.
25. Meduri GU, Headley S, Tolley E, et al: Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995;108:1315-25.
26. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.
27. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108:1303-14.
28. Hesterberg TW, Last JA: Ozone-induced acute pulmonary fibrosis in rats-Prevention of increased rates of collagen synthesis by methylprednisolone. Am Rev Respir Dis 1981;123:47-52.
29. Hooper RG, Kearl RA: Established ARDS treated with a sustained course of adrenocortical steroids. Chest 1990;97:138-43.
30. Cheung CY, Poon LL, Lau AS, et al: Induction of postinflammatory cytokines in human macrophages by influenza A (H5N1) virus: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831-7.
31. Papi A, Papadopoulos NG, Degitz K, et al: Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up regulation and promoter activation on respiratory epithelial cells. J Allergy Clin Immunol 2000;105:318-26.
32. Anderlini P, Buzaid AC, Legha SS: Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer 1995;76: 678-9.
33. Phillips RA: The relationship between proinflammatory mediators and heat stress induced rhabdomyolysis in exercising marines. Crit Care Nurs Clin North Am 2003;15:163-70.
34. Huang KJ, Su IJ, Theron M, et al: An interferon-γ related cytokine storm in SARS patients. J Med Virol 2005;75:185-94.
35. Wang WK, Chen SY, Liu IJ, et al: Temporal relationship of viral load, ribavirin, interleukin(IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis 2004;39:1071-5.
36. Zhang Y, Li J, Zhan Y, et al: Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 2004;72: 4410-5.